跳至主要内容
临床试验/DRKS00034789
DRKS00034789已完成不适用

Feasibility and safety of minimally invasive R1 vascular surgery for hepatocellular carcinoma: a cohort study

Chirurgische Klinik, Universitätsmedizin Mannheim0 个研究点目标入组 58 人开始时间: 2024年7月29日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
58

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Patients were eligible for inclusion if they were aged 18 years or older, underwent a curative, minimally invasive parenchymal-sparing hepatectomy for HCC, and had adequate preoperative imaging, including contrast-enhanced computed tomography (CT) and/or magnetic resonance imaging (MRI).

排除标准

  • Missing preoperative imaging
  • non curative resections

研究者

发起方
Chirurgische Klinik, Universitätsmedizin Mannheim

相似试验

Feasibility and safety of minimally invasive R1... | 临床试验